Transparent Elastomeric Respirator for Aerosol-based Protection
NCT ID: NCT04511390
Last Updated: 2021-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2020-07-25
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing the Pro-ischaemic Effects of Air Pollution Exposure Using a Simple Face Mask
NCT00809653
Residential Ventilation Systems and Filtration for Asthma Control in Adults
NCT06098287
Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
NCT03744871
Face Masks to Reduce the Adverse Effects of Diesel Exhaust Inhalation
NCT02729129
In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors
NCT06778122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Some disadvantages of EHMRs include the requirement to disinfect and reinspect the quality of components on the respirator by a qualified individual for proper function, as well as manual exchange of filter components. Notwithstanding, it has been found that fit testing and training to use EHMRs for healthcare personnel is not significantly different than N95 respirators and that EHMR may serve as a suitable alternative to disposable N95 respirators during public health emergencies. Furthermore, a 2018 consensus report from the National Academies of Engineering, Science, and Medicine recommended that the durability and reusability of elastomeric respirators made them desirable for stockpiling for emergencies.
A new transparent elastomeric respirator has been developed that can maintain respirator integrity after decontamination and fits many people with different face sizes and shapes. Fit testing of the respirator will be performed using an OSHA-approved testing method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transparent, reusable respirator
Transparent, reusable elastomeric respirator that has been designed to fit multiple different face sizes and shapes.
Transparent, reusable respirator
A novel respirator with dual N95 filter cartridges
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transparent, reusable respirator
A novel respirator with dual N95 filter cartridges
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
C. Giovanni Traverso MB Bchir PhD
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020P000852
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.